Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage
NCT01275794
·
clinicaltrials.gov ↗
COMPLETED
Status
1849
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes
Sponsor
AstraZeneca
Collaborators
[object Object]